CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Cn Bio Innovations has raised €28M across 2 funding rounds from 2 investors, most recently a Series B round in Apr 2024. Based in Welwyn Garden City, UK; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-04-23 | Series B | €20M | Bayland Capital,CN Innovations Holdings | View deal → |
| 2020-02-03 | Other | €8.1M | — | View deal → |
